false Q3 --12-31 2025-09-30 2025 0001786286 0001786286 2025-01-01 2025-09-30 0001786286 2025-09-30 0001786286 2024-12-31 0001786286 2025-07-01 2025-09-30 0001786286 2024-07-01 2024-09-30 0001786286 2024-01-01 2024-09-30 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:WarrantReserveMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-09-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-09-30 0001786286 ifrs-full:WarrantReserveMember 2024-09-30 0001786286 ifrs-full:RetainedEarningsMember 2024-09-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-09-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-09-30 0001786286 2024-09-30 0001786286 ifrs-full:IssuedCapitalMember 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-09-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-09-30 0001786286 ifrs-full:WarrantReserveMember 2024-01-01 2024-09-30 0001786286 ifrs-full:RetainedEarningsMember 2024-01-01 2024-09-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-01-01 2024-09-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-09-30 0001786286 ifrs-full:IssuedCapitalMember 2024-10-01 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-10-01 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-10-01 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-10-01 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-10-01 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-10-01 2024-12-31 0001786286 2024-10-01 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-01-01 2025-09-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:WarrantReserveMember 2025-01-01 2025-09-30 0001786286 ifrs-full:RetainedEarningsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-01-01 2025-09-30 0001786286 ifrs-full:IssuedCapitalMember 2025-09-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-09-30 0001786286 ifrs-full:WarrantReserveMember 2025-09-30 0001786286 ifrs-full:RetainedEarningsMember 2025-09-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-09-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-09-30 0001786286 DPRO:DragonflyInnovationsIncMember 2025-01-01 2025-09-30 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2025-01-01 2025-09-30 0001786286 DPRO:DronelogicsSystemsIncMember 2025-01-01 2025-09-30 0001786286 ifrs-full:PreviouslyStatedMember 2024-07-01 2024-09-30 0001786286 ifrs-full:PreviouslyStatedMember 2024-01-01 2024-09-30 0001786286 2024-01-01 2024-12-31 0001786286 DPRO:InventoryMember 2025-07-01 2025-09-30 0001786286 DPRO:InventoryMember 2024-07-01 2024-09-30 0001786286 DPRO:InventoryMember 2025-01-01 2025-09-30 0001786286 DPRO:InventoryMember 2024-01-01 2024-09-30 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-01-01 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-01-01 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-01-01 2025-09-30 0001786286 DPRO:FurnitureAndEquipmentMember 2025-01-01 2025-09-30 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:VehiclesMember 2025-01-01 2025-09-30 0001786286 ifrs-full:ComputerEquipmentMember 2025-09-30 0001786286 DPRO:FurnitureAndEquipmentMember 2025-09-30 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-09-30 0001786286 ifrs-full:VehiclesMember 2025-09-30 0001786286 ifrs-full:BuildingsMember 2023-12-31 0001786286 ifrs-full:LandMember 2023-12-31 0001786286 ifrs-full:BuildingsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:LandMember 2024-01-01 2024-12-31 0001786286 ifrs-full:BuildingsMember 2024-12-31 0001786286 ifrs-full:LandMember 2024-12-31 0001786286 ifrs-full:BuildingsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:LandMember 2025-01-01 2025-09-30 0001786286 ifrs-full:BuildingsMember 2025-09-30 0001786286 ifrs-full:LandMember 2025-09-30 0001786286 ifrs-full:BottomOfRangeMember 2025-09-30 0001786286 ifrs-full:TopOfRangeMember 2025-09-30 0001786286 ifrs-full:NotLaterThanOneYearMember 2025-09-30 0001786286 ifrs-full:NotLaterThanOneYearMember 2024-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2025-09-30 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2024-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2025-09-30 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2025-01-01 2025-09-30 0001786286 DPRO:CommonStock1Member 2025-05-05 0001786286 2025-05-05 2025-05-05 0001786286 ifrs-full:OrdinarySharesMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember DPRO:OverAllotmentMember 2025-05-05 0001786286 ifrs-full:OrdinarySharesMember DPRO:OverAllotmentMember 2025-05-05 0001786286 ifrs-full:OrdinarySharesMember DPRO:OverAllotmentMember 2025-05-05 2025-05-05 0001786286 DPRO:CommonStock1Member 2025-06-12 0001786286 2025-06-12 2025-06-12 0001786286 ifrs-full:OrdinarySharesMember 2025-06-12 2025-06-12 0001786286 ifrs-full:WarrantsMember 2025-06-12 2025-06-12 0001786286 DPRO:CommonStock1Member 2025-07-21 0001786286 2025-07-21 2025-07-21 0001786286 ifrs-full:OrdinarySharesMember 2025-07-21 2025-07-21 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 0001786286 2024-02-26 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 2024-02-26 0001786286 ifrs-full:WarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-03-27 0001786286 DPRO:PrefundedWarrantsMember 2024-03-26 0001786286 DPRO:PrefundedWarrantsMember 2025-09-30 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 0001786286 2024-04-29 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 2024-04-29 0001786286 ifrs-full:WarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:PrefundedWarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:CommonStock1Member 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 0001786286 2024-08-21 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 2024-08-21 0001786286 ifrs-full:WarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:PrefundedWarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:CommonStock1Member 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 0001786286 2024-11-19 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 2024-11-19 0001786286 ifrs-full:WarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:PrefundedWarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:StockOptionsMember 2025-07-01 2025-09-30 0001786286 DPRO:StockOptionsMember 2024-07-01 2024-09-30 0001786286 DPRO:StockOptionsMember 2025-01-01 2025-09-30 0001786286 DPRO:StockOptionsMember 2024-01-01 2024-09-30 0001786286 DPRO:RestrictedStockUnitsMember 2025-07-01 2025-09-30 0001786286 DPRO:RestrictedStockUnitsMember 2024-07-01 2024-09-30 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-09-30 0001786286 2024-08-07 2024-08-07 0001786286 DPRO:OctoberWarrantsMember 2024-08-07 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-09-30 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:IncentiveShareCompensationPlanMember 2025-09-30 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2024-01-01 2024-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2024-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2025-01-01 2025-09-30 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2025-09-30 0001786286 ifrs-full:WarrantsMember DPRO:FebruaryIssuanceMember 2025-01-01 2025-09-30 0001786286 DPRO:BrokerMember DPRO:FebruaryIssuanceMember 2025-01-01 2025-09-30 0001786286 ifrs-full:WarrantsMember DPRO:AprilIssuanceMember 2025-01-01 2025-09-30 0001786286 DPRO:BrokerMember DPRO:AprilIssuanceMember 2025-01-01 2025-09-30 0001786286 DPRO:BrokerMember DPRO:AugustIssuanceMember 2025-01-01 2025-09-30 0001786286 DPRO:BrokerMember DPRO:NovemberIssuanceMember 2025-01-01 2025-09-30 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:WarrantsMember 2025-09-30 0001786286 DPRO:RangeOneMember 2025-01-01 2025-09-30 0001786286 DPRO:RangeOneMember 2025-09-30 0001786286 DPRO:RangeOneMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-09-30 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 DPRO:WarrantOneMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantOneMember 2025-09-30 0001786286 DPRO:WarrantOneMember 2024-12-31 0001786286 DPRO:WarrantTwoMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantTwoMember 2025-09-30 0001786286 DPRO:WarrantTwoMember 2024-12-31 0001786286 DPRO:WarrantThreeMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantThreeMember 2025-09-30 0001786286 DPRO:WarrantThreeMember 2024-12-31 0001786286 DPRO:WarrantFourMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantFourMember 2025-09-30 0001786286 DPRO:WarrantFourMember 2024-12-31 0001786286 DPRO:WarrantFiveMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantFiveMember 2025-09-30 0001786286 DPRO:WarrantFiveMember 2024-12-31 0001786286 DPRO:WarrantSixMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantSixMember 2025-09-30 0001786286 DPRO:WarrantSixMember 2024-12-31 0001786286 DPRO:WarrantSevenMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantSevenMember 2025-09-30 0001786286 DPRO:WarrantSevenMember 2024-12-31 0001786286 DPRO:WarrantEightMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantEightMember 2025-09-30 0001786286 DPRO:WarrantEightMember 2024-12-31 0001786286 DPRO:WarrantNineMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantNineMember 2025-09-30 0001786286 DPRO:WarrantNineMember 2024-12-31 0001786286 DPRO:WarrantTenMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantTenMember 2025-09-30 0001786286 DPRO:WarrantTenMember 2024-12-31 0001786286 DPRO:WarrantElevenMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantElevenMember 2025-09-30 0001786286 DPRO:WarrantElevenMember 2024-12-31 0001786286 DPRO:WarrantTwelveMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantTwelveMember 2025-09-30 0001786286 DPRO:WarrantTwelveMember 2024-12-31 0001786286 DPRO:WarrantThirteenMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantThirteenMember 2025-09-30 0001786286 DPRO:WarrantThirteenMember 2024-12-31 0001786286 DPRO:WarrantFourteenMember 2025-01-01 2025-09-30 0001786286 DPRO:WarrantFourteenMember 2025-09-30 0001786286 DPRO:WarrantFourteenMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-09-30 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 DPRO:DronesMember 2025-01-01 2025-09-30 0001786286 DPRO:CorporatesMember 2025-01-01 2025-09-30 0001786286 DPRO:DronesMember 2024-01-01 2024-09-30 0001786286 DPRO:CorporatesMember 2024-01-01 2024-09-30 0001786286 DPRO:CAMember 2025-09-30 0001786286 DPRO:CAMember 2024-12-31 0001786286 DPRO:USCountryMember 2025-09-30 0001786286 DPRO:USCountryMember 2024-12-31 0001786286 DPRO:CAMember 2025-07-01 2025-09-30 0001786286 DPRO:CAMember 2024-07-01 2024-09-30 0001786286 DPRO:CAMember 2025-01-01 2025-09-30 0001786286 DPRO:CAMember 2024-01-01 2024-09-30 0001786286 DPRO:USCountryMember 2025-07-01 2025-09-30 0001786286 DPRO:USCountryMember 2024-07-01 2024-09-30 0001786286 DPRO:USCountryMember 2025-01-01 2025-09-30 0001786286 DPRO:USCountryMember 2024-01-01 2024-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2025-07-01 2025-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2024-07-01 2024-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2025-01-01 2025-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2024-01-01 2024-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2025-09-30 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2024-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2025-07-01 2025-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2024-07-01 2024-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2025-01-01 2025-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2024-01-01 2024-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2025-09-30 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2024-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2025-07-01 2025-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2024-07-01 2024-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2025-01-01 2025-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2024-01-01 2024-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2025-09-30 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2024-09-30 0001786286 DPRO:CEOAndDirectorMember 2025-07-01 2025-09-30 0001786286 DPRO:CEOAndDirectorMember 2024-07-01 2024-09-30 0001786286 DPRO:CEOAndDirectorMember 2025-01-01 2025-09-30 0001786286 DPRO:CEOAndDirectorMember 2024-01-01 2024-09-30 0001786286 DPRO:CEOMember 2025-07-01 2025-09-30 0001786286 DPRO:CEOMember 2024-07-01 2024-09-30 0001786286 DPRO:CEOMember 2025-01-01 2025-09-30 0001786286 DPRO:CEOMember 2024-01-01 2024-09-30 0001786286 DPRO:DirectorsMember 2025-07-01 2025-09-30 0001786286 DPRO:DirectorsMember 2024-07-01 2024-09-30 0001786286 DPRO:DirectorsMember 2025-01-01 2025-09-30 0001786286 DPRO:DirectorsMember 2024-01-01 2024-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2025-07-01 2025-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-07-01 2024-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2025-01-01 2025-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-09-30 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2025-09-30 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2025-09-30 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2025-01-01 2025-09-30 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-01-01 2024-12-31 0001786286 DPRO:NonadjustingEventsMember 2025-10-01 2025-10-01 0001786286 DPRO:OctoberThirtyTwentyTwentyThreeMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:FebruaryTwentySixTwentyTwentyFourMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:AprilTwentyNineTwentyTwentyFourMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:NovemberNineteenTwentyTwentyFourMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:MayFiveTwentyTwentyFiveMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:JuneTwelveTwentyTwentyFiveMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:JulyTwentyOneTwentyTwentyFiveMember DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:WarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:FebruaryTwentySixTwentyFourMember DPRO:BrokerWarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:AprilTwentyNineTwentyTwentyFourMember DPRO:BrokerWarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:MayFiveTwentyTwentyFiveMember DPRO:BrokerWarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:JulyTwentyOneTwentyFiveMember DPRO:BrokerWarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 DPRO:BrokerWarrantsIssuanceMember 2025-10-01 2025-10-01 0001786286 2025-10-01 2025-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure DPRO:Segments iso4217:CAD xbrli:shares iso4217:CAD

 

Exhibit 99.1

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Financial Statements - Unaudited

For the Three and Nine Months Ended September 30, 2025

(Expressed in Canadian Dollars)

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Financial Position - Unaudited

Expressed in Canadian Dollars

 

 

      September 30,   December 31, 
As at  Notes  2025   2024 
            
ASSETS             
Current Assets             
Cash     $69,881,348   $6,252,409 
Receivables  4   1,249,555    573,390 
Inventory  5   2,930,594    1,532,263 
Prepaids and deposits  6   1,913,632    724,513 
Total current assets      75,975,129    9,082,575 
              
Equipment  7   780,836    529,542 
Intangible assets      38,370    45,141 
Investments      21,428    14,286 
Receivable  4   -    156,200 
Right of use assets  8   265,298    372,344 
TOTAL ASSETS     $77,081,061   $10,200,088 
              
LIABILITIES AND SHAREHOLDERS’ EQUITY             
Current Liabilities             
Trade payables and accrued liabilities  10,16  $2,997,745   $2,399,187 
Customer deposits      81,415    466,295 
Deferred income  11   168,637    18,542 
Derivative liability  12   3,037,087    2,198,121 
Lease liabilities  9   151,033    154,147 
Total current liabilities      6,435,917    5,236,292 
              
Non-current Liabilities             
Deferred Income  11   49,908    68,139 
Lease liabilities  9   162,815    273,874 
TOTAL LIABILITIES      6,648,640    5,578,305 
              
SHAREHOLDERS’ EQUITY             
Share capital  12   188,400,703    110,742,984 
Reserves – share-based payments  12   8,898,765    7,698,304 
Reserves - warrants      4,337,236    3,776,428 
Accumulated deficit      (130,822,612)   (117,465,829)
Accumulated other comprehensive income      (381,671)   (130,104)
TOTAL SHAREHOLDERS’ EQUITY      70,432,421    4,621,783 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY     $77,081,061   $10,200,088 

 

Nature and Continuance of Operations (Note 1)

Subsequent events (Note 18)

 

Approved and authorized for issuance by the Board of Directors on November 12, 2025.

 

“Scott Larson”   “Cameron Chell”
Director   Director

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

2

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Comprehensive loss - Unaudited

Expressed in Canadian Dollars

 

 

      September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
      For the three months ended   For the nine months ended 
      September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
                    
Sales of goods  13  $1,622,286   $1,328,675   $5,065,682   $3,953,974 
Provision of services  13   533,707    556,647    753,281    993,920 
TOTAL REVENUE      2,155,993    1,885,322    5,818,963    4,947,894 
                        
COST OF SALES  5   (1,735,046)   (1,444,542)   (4,583,337)   (3,765,429)
                        
GROSS PROFIT      420,947    440,780    1,235,626    1,182,465 
                        
OPERATING EXPENSES                       
Amortization     $2,257   $2,821   $6,771   $8,464 
Depreciation  7,8   85,939    139,358    234,403    424,039 
Director fees  16   122,965    131,469    394,803    375,369 
Insurance      157,314    234,279    468,315    954,259 
Office and miscellaneous  14   1,330,796    620,696    3,209,956    1,699,555 
Professional fees      85,395    424,717    691,458    1,229,244 
Research and development      321,331    347,373    609,029    659,832 
Share-based payments  12,16   474,729    400,575    1,139,063    904,629 
Travel      302,573    57,436    607,615    174,367 
Employee and management expenses  16   2,463,477    1,766,354    6,870,712    5,622,176 
Total operating expenses      (5,346,776)   (4,125,078)   (14,232,125)   (12,051,934)
OTHER INCOME (EXPENSE)                       
Change in fair value of derivative liability  12   (1,837,618)   3,575,559    (1,860,107)   2,788,734 
Finance and other gain      366,000    38,632    410,494    85,436 
Foreign exchange gain (loss)      1,127,680    (48,216)   1,023,272    26,344 
Gain (loss) on disposal of assets      16,545    7,846    16,242    32,148 
Gain (loss) on recovery (impairment) of notes receivable      35,461    7,564    69,646    18,425 
Other income (expense)  15   47,964    (97,281)   (19,831)   (1,237,169)
 Total Other operating income     $(243,968)  $3,484,104   $(360,284)  $1,713,918 
NET LOSS     $(5,169,797)  $(200,194)  $(13,356,783)  $(9,155,551)
OTHER COMPREHENSIVE INCOME (LOSS)                       
Items that may be reclassified to profit or loss                       
Foreign exchange translation      (248,065)   1,086    (258,710)   (15,935)
Items that will not be reclassified to profit or loss                       
Change in fair value of equity investments at FVOCI      (7,142)   (165,441)   7,143    (175,117)
COMPREHENSIVE LOSS      (5,425,004)   (364,549)   (13,608,350)   (9,346,603)
                        
Net Loss per share – Basic & diluted     $(0.25)  $(0.06)  $(1.17)  $(3.28)
Weighted average number of common shares outstanding – Basic & diluted      20,555,945    3,351,778    11,379,877    2,794,072 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited

Expressed in Canadian Dollars

 

 

   Number of Shares   Share Capital   Reserve – Share-Based Payments  

 

 

 

Reserves – Warrants

   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total Shareholders’ Equity 
                       Accumulated Other Comprehensive Income (Loss) 
   Number of Shares   Share Capital   Reserve – Share-Based Payments  

 

 

 

Reserves – Warrants

   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total Shareholders’ Equity 
Balance at December 31, 2023   1,969,566   $97,070,976   $6,870,139   $-   $(103,588,356)  $(434,303)  $489,260   $407,716 
Shares issued for financing   1,077,208    5,111,911    -    -    -    -    -    5,111,911 
Share issue costs   -    (877,474)   327,696    -    -    -    -    (549,778)
Shares issued for the exercise of warrants   791,668    4,056,657    -    -    -    -    -    4,056,657 
Shares issued for the exercise of RSUs   22,766    829,361    (829,361)   -    -    -    -    - 
Warrants – equity treatment   -    -    -    3,776,428                   3,776,428 
Share-based payments   -    -    904,628    -    -    -    -    904,628 
Shares returned to treasury   (36,000)   -    -    -    -    -    -    - 
Net loss   -    -    -    -    (9,155,551)   -    -    (9,155,551)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (175,117)   -    (175,117)
Translation of foreign operations   -    -    -    -    -    -    (15,935)   (15,935)
Balance at September 30, 2024   3,825,208   $106,191,431   $7,273,102   $3,776,428   $(112,743,907)  $(609,420)  $473,325   $4,360,959 
Shares issued for financing   400,000    5,272,234    -    -    -    -    -    5,272,234 
Share issue costs   -    (755,397)   181,758    -                   (573,639)
Shares issued for the exercise of warrant   1,200,000    171    -    -    -    -    -    171 
Shares issued for the exercise of RSUs   2,587    34,545    (34,545)   -    -    -    -    - 
Share-based payments   -    -    277,989    -    -    -    -    277,989 
Net loss   -    -    -    -    (4,721,922)   -    -    (4,721,922)
Translation of foreign operations   -    -    -    -    -    -    5,991    5,991 
Balance at December 31, 2024   5,427,795   $110,742,984   $7,698,304   $3,776,428   $(117,465,829)  $(609,420)  $479,316   $4,621,783 
Unites issued for financing   11,887,895    56,907,745    -    1,103,825    -    -    -    58,011,570 
Share issue costs   -    (7,203,673)   2,225,727    -    -    -    -    (4,977,946)
Shares issued for exercise of overallotment   100,000    294,000    -    -    -    -    -    294,000 
Share issue costs – overallotment   -    (28,030)   -    -    -    -    -    (28,030)
Shares issued for the exercise of warrants   5,711,131    26,438,554    (915,207)   (543,017)   -    -    -    24,980,330 
Shares issued for the exercise of RSUs   134,191    1,249,123    (1,249,123)   -    -    -    -    - 
Share-based payments   -    -    1,139,063    -    -    -    -    1,139,063 
Net loss   -    -    -    -    (13,356,783)   -    -    (13,356,783)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    7,143    -    7,143 
Translation of foreign operations   -    -    -    -    -    -    (258,710)   (258,710)
Balance at September 30, 2025   23,261,012   $188,400,703   $8,898,765   $4,337,236   $(130,822,612)  $(602,277)  $220,606   $70,432,421 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Cash Flows - Unaudited

Expressed in Canadian Dollars

 

 

   2025   2024 
   For the nine months ended September 30, 
   2025   2024 
         
OPERATING ACTIVITIES          
Net loss  $(13,356,783)  $(9,155,551)
Adjustments for:          
Amortization   6,771    8,464 
Depreciation   234,403    424,039 
Impairment of accounts receivable   (11,882)   - 
Change in fair value of derivative liability   1,860,107    (2,788,734)
Impairment of inventory   15,091    148,760 
Gain on recovery of notes receivable   (69,646)   (18,425)
Finance and other costs   45,812    1,204,434 
Gain on disposal of assets   11,469    (22,553)
Share-based payments   1,139,063    904,629 
Adjustments for profit loss   (10,125,595)   (9,294,937)
Net changes in non-cash working capital items:          
Receivables   (508,083)   (360,757)
Inventory   (1,376,773)   (62,595)
Prepaids   (1,189,119)   369,747 
Trade payables and accrued liabilities   (683,423)   (220,627)
Customer deposits   (384,880)   (9,363)
Deferred income   131,864    (24,574)
Cash used in operating activities   (14,136,009)   (9,603,106)
           
INVESTING ACTIVITIES          
Purchase of equipment   (426,770)   (73,027)
Disposal of equipment   -    103,923 
Repayment of notes receivable   69,646    18,425 
Cash provided by (used in) investing activities   (357,124)   49,321 
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   58,277,541    12,479,693 
Share issue costs   (5,005,668)   (2,036,067)
Proceeds from issuance of common shares for warrants exercised   23,941,100    373,244 
Repayment of loans   -    (85,058)
Repayment of lease liabilities   (114,173)   (258,127)
Cash provided by financing activities   77,098,800    10,473,685 
           
Effects of exchange rate changes on cash   1,023,272    (15,935)
Change in cash   62,605,667    919,900 
Cash and cash equivalents, beginning of period   6,252,409    3,093,612 
Cash and cash equivalents, end of period  $69,881,348   $3,997,577 
           
SUPPLEMENTARY CASH FLOW DISCLOSURE          
Interest paid  $9,820   $15,428 
Share issue costs in accounts payable   -    71,912 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited) 

 

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $130,822,612. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These condensed consolidated interim financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

2. BASIS OF PREPARATION

 

Statement of Compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2024.

 

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on November 12, 2025.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (“DII”)  Canada   100%
Draganfly Innovations USA, Inc. (“DI USA”)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

6

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited) 

 

 

2.BASIS OF PRESENTATION (CONT’D)

 

Reclassification

 

Certain prior year amounts have been reclassified to conform to the fiscal 2025 presentation. Overall results were not impacted by the reclassification of items within the Operating Expenses of the Condensed Consolidated Statements of Comprehensive Loss. For the three and nine months ended September 30, 2024 $349,352 and $1,013,563 was moved out of professional fees with $237,210 and $689,993 going to employee and management costs and $112,142 and $323,570 going to office and miscellaneous.

 

3. MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS

 

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as outlined in the Company’s consolidated financial statements for the year ended December 31, 2024. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual financial statements for the year ended December 31, 2024.

 

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2024.

 

4. RECEIVABLES

 

As at  September 30,
2025
   December 31,
2024
 
Trade accounts receivable  $1,135,754   $674,998 
Sales tax receivable   113,801    54,592 
Trade and other receivables, gross   $1,249,555   $729,590 
Current portion  $1,249,555   $573,390 
Long term portion   -    156,200 
Trade and other receivables, net   $1,249,555   $729,590 

 

Expected credit loss

 

Balance at December 31, 2023   289,495 
Increase during the year   140,011 
Balance at December 31, 2024   429,506 
Decrease during the period   (11,882)
Balance at September 30, 2025  $417,624 

 

During the nine months ended September 30, 2025, the Company recorded a reduction in the allowance for doubtful accounts of $11,882 (2024 – $40,409).

 

7

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited) 

 

 

4.RECEIVABLES (CONT’D)

 

The Company assumes that the credit risk on a financial asset has increased if it is outstanding beyond the agreed payment terms. The Company considers a receivable to be default when the customer is unlikely to pay its obligations to the Company in full. The carrying amount of a receivable is written off (either partially or in full) to the extent that there is no realistic prospect of recovery.

 

Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

5. INVENTORY

 

As at  September 30,
2025
   December 31,
2024
 
Finished goods  $1,591,500   $954,453 
Parts   1,339,094    577,810 
Inventories   $2,930,594   $1,532,263 

 

During the three and nine months ended September 30, 2025, $1,363,053 (2024 - $1,152,068) and $3,844,309 (2024 – $3,296,218) of inventory was recognized in cost of sales respectively including an allowance to value its inventory for obsolete and slow-moving inventory of $43,337 (2024-$176,422) and $15,091 (2024-$459,591) respectively.

 

Cost of sales consist of the following:

 

   September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
   For the three months ended   For the nine months ended 
   September 30, 2025   September 30, 2024   September 30, 2025   September 30, 2024 
Inventory  $1,363,053   $1,152,068   $3,844,309   $3,296,218 
Consulting and services   259,676    279,598    464,612    418,035 
Other   112,317    12,876    274,416    51,176 
Cost of sales   $1,735,046   $1,444,542   $4,583,337   $3,765,429 

 

6. PREPAIDS AND DEPOSITS

 

As at  September 30, 2025   December 31, 2024 
Insurance  $540,183   $370,609 
Prepaid other   282,529    112,439 
Deposits   1,090,920    241,465 
Prepaid expenses and deposits   $1,913,632   $724,513 

 

Deposits consist of amounts required to be pre-paid in order for vendors to manufacture or supply goods.

 

8

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim

Financial Statements For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

7. EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Vehicles   Total 
Cost                         
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $60,343   $1,320,338 
Additions   6,876    137,562    2,359    -    146,797 
Disposals   (9,821)   (180,338)   -    -    (190,159)
Balance at December 31, 2024   130,328    997,416    88,889    60,343    1,276,976 
Additions   31,607    432,130    1,300    -    465,037 
Disposals   (17,668)   (119,379)   (38,266)   -    (175,313)
Balance at September 30, 2025  $144,267   $1,310,167   $51,923   $60,343   $1,566,700 
                          
Accumulated depreciation                         
Balance at December 31, 2023  $58,178   $545,403   $6,790   $29,166   $639,537 
Charge for the year   37,881    143,885    17,845    9,354    208,965 
Disposals   (3,383)   (97,685)   -    -    (101,068)
Balance at December 31, 2024   92,676    591,603    24,635    38,520    747,434 
Charge for the period   23,869    138,536    9,797    4,911    177,113 
Disposals   (14,395)   (111,582)   (12,706)   -    (138,683)
Balance at September 30, 2025  $102,150   $618,557   $21,726   $43,431   $785,864 
                          
Net book value:                         
December 31, 2024  $37,652   $405,813   $64,254   $21,823   $529,542 
September 30, 2025  $42,117   $691,610   $30,197   $16,912   $780,836 

 

8. RIGHT OF USE ASSETS

 

   Buildings   Land   Total 
             
Balance at December 31, 2023  $515,071   $206,616   $721,687 
Depreciation   (142,727)   (214,114)   (356,841)
Foreign exchange translation   -    7,498    7,498 
Balance at December 31, 2024  $372,344   $-   $372,344 
Depreciation   (107,046)   -    (107,046)
Balance at September 30, 2025  $265,298   $-   $265,298 

 

There were no additions to the right of use assets during the three and nine months ended September 30, 2025 nor the year ended December 31, 2024.

 

9

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim

Financial Statements For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

9. LEASE LIABILITIES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

 

   Total 
Balance at December 31, 2023  $790,023 
Interest expense    65,378 
Lease payments    (423,157)
Foreign exchange translation   (4,223)
Balance at December 31, 2024   428,021 
Interest expense   28,969 
Lease payments   (143,142)
Balance at September 30, 2025  $313,848 

 

Which consists of:

 

   September 30,
2025
  

December 31,

2024

 
Current lease liability  $151,033   $154,147 
Non-current lease liability   162,815    273,874 
Ending balance  $313,848   $428,021 

 

Maturity analysis  September 30,
2025
   December 31,
2024
 
Less than one year  $176,094   $190,856 
One to three years   178,161    282,419 
Four to five years   -    71,836 
Total undiscounted lease liabilities   354,255    545,111 
Amount representing interest   (40,407)   (117,090)
Lease liability   $313,848   $428,021 

 

10. TRADE PAYABLES AND ACCRUED LIABILITIES

 

As at  September 30,
2025
   December 31,
2024
 
Trade accounts payable (note 16)  $801,602   $609,869 
Accrued liabilities   2,196,143    1,789,318 
Trade payables and accrued liabilities   $2,997,745   $2,399,187 

 

10

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

11. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   September 30,
2025
   December 31,
2024
 
Deferred, revenue beginning  $86,681   $107,674 
Revenue recognized   (31,871)   (21,852)
Unearned revenues received   169,329    1,744 
Foreign exchange   (5,594)   (885)
Deferred income gross   $218,545   $86,681 
Current portion  $168,637   $18,542 
Long term portion   49,908    68,139 
Deferred Income net   $218,545   $86,681 

 

Deferred revenue of $168,637 as of September 30, 2025 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 2.33 years.

 

12. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the nine months ended September 30, 2025,

 

The Company issued 134,191 common shares for the vesting of restricted share units.
On May 5, 2025, the Company issued 1,715,000 units consisting of one common share and one warrant and in a financing for $4,973,404 with share issue costs of $665,659 for net proceeds of $4,307,745. The value of the issuance was allocated $4,545,997 to the shares and $427,407 to the warrants. This issuance included an overallotment of 100,000 warrants convertible to 100,000 shares. Warrants were valued using the residual method.
The Company issued 100,000 shares related to the overallotment of the May 5, 2025 share issuance for gross proceeds of $290,000 with share issue costs of $28,030 for net proceeds of $265,970.
On June 12, 2025 the Company issued 5,500,000 units consisting of one common share and one warrant in a financing for $18,758,889 with share issue costs of $1,625,345 for net proceeds of $17,113,545. The value of the issuance was allocated $18,082,472 to the shares and $676,418 to the warrants. Warrants were valued using the residual method.
On July 21, 2025 the Company issued 4,672,895 units consisting of one common share and one warrant in a financing for $34,279,276 with share issue costs of $2,686,635 for net proceeds of $31,592,641.
5,711,131 shares were issued for the exercise of warrants

 

During the year ended December 31, 2024,

 

The Company issued 25,353 common shares for the vesting of restricted share units.
The Company issued 1,991,668 common shares for the exercise of warrants

 

11

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.SHARE CAPITAL (CONT’D)

 

On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025. 36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. The shares had a carrying value of $nil on cancellation.
On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615 for net proceeds of $4,102,553. Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.
On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676 for net proceeds of $2,376,374. The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.
On November 19, 2024 the Company issued 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant in a financing for $5,272,234 with share issue costs of $755,397 for net proceeds of $4,516,837. The value of the issuance was allocated $329,515 to the shares and $4,942,719 to the warrants including $1,977,088 allocated to the prefunded warrants.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

As at September 30, 2025, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $62.50    4.08    10,464    10,464 
April 30, 2020  April 30, 2030  $62.50    4.58    240    240 
April 30, 2020  April 30, 2030  $96.25    4.58    4,400    4,400 
November 24, 2020  November 24, 2030  $62.50    5.15    1,280    1,280 
February 2, 2021  February 2, 2031  $330.00    5.35    1,200    1,200 
March 8, 2021  March 8, 2026  $347.50    0.44    400    400 
April 27, 2021  April 27, 2031  $253.75    5.58    3,640    3,640 
September 9, 2021  September 9, 2026  $121.00    0.94    1,034    1,034 
November 9, 2023  November 9, 2033  $15.75    8.12    1,200    800 
                 23,858    23,458 

 

12

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.SHARE CAPITAL (CONT’D)

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2023   35,954   $112.00 
Forfeited   (4,350)   106.83 
Outstanding, December 31, 2024   31,604   $112.05 
Expired   (4,000)   80.00 
Forfeited   (3,746)   113.55 
Outstanding, September 30, 2025   23,858   $116.34 

 

No options were granted by the Company during the nine months ended September 30, 2025.

 

During the three and nine months ended September 30, 2025, the Company recorded $1,013 (2024 – $5,600) and $3,040 (2024 - $58,978) respectively in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model.

 

Restricted Share Units

 

During the three and nine months ended September 30, 2025, the Company recorded share-based payment expense of $473,716 (2024 - $394,975) and $1,136,023 (2024 - $845,650) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at September 30, 2025, the Company had the following RSUs outstanding:

 

   Number of RSUs   Average Price 
Outstanding, December 31, 2023   44,545   $32.45 
Vested   (25,353)   35.63 
Issued   185,240    8.99 
Forfeited   (16,332)   13.41 
Outstanding, December 31, 2024   188,100    10.74 
Vested   (134,191)   13.10 
Issued   450,964    2.55 
Forfeited   (9,175)   10.78 
Outstanding, September 30, 2025   495,698   $3.86 

 

13

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.SHARE CAPITAL (CONT’D)

 

Warrants

 

During the year ended December 31, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company’s functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD and are also accounted for as a liability. In addition, the Company issued pre-funded warrants with an exercise price in Canadian dollars (“Pre-funded Warrants”). These are treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are accounted for as a liability as these contain clauses that do not meet the fixed for fixed test.

 

On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to $5.625. The exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of $5.6925. For the October 2023 issuance and the April 2024 issuance, the warrant agreements were further amended as of August 7, 2024 to remove the cashless exercise feature and any anti-dilution clauses that would lead to variability in settlement so they now meet the requirement for equity classification. The warrants were fair valued on August 7, 2024 and transferred to equity.

 

To determine the fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

 

2024 Issuances  February Issuance   April Issuance   August Issuance   November Issuance 
   Warrants   Broker   Warrants   Broker   Broker   Broker 
Volatility   119.23%   107.8%   119.80%   108.67%   118.87%   115.27%
Risk free rate   4.33%   4.48%   4.65%   4.62%   3.74%   4.24%
Expected life   5 years    3 years    5 years    3 years    3 years    3 years 
Expected dividend yield   0%   0%   0%   0%   0%   0%

 

Warrant Derivative Liability

 

Balance at December 31, 2023  $4,196,125 
Warrants issued   7,282,325 
Exercised   (3,661,283)
Change in fair value of warrants outstanding   (1,842,618)
Reclassify to equity   (3,776,428)
Balance at December 31, 2024  $2,198,121 
Exercised   (1,021,141)
Change in fair value of warrants outstanding   1,860,107 
Balance at September 30, 2025  $3,037,087 

 

14

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.SHARE CAPITAL (CONT’D)

 

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise
Price
  

Number of Warrants
Outstanding at

September 30, 2025

   Fair Value at
September 30, 2025
   Number of Warrants
Outstanding at
December 31, 2024
   Fair Value at
December 31, 2024
 
Derivative Liability                    
February 26, 2024 (1)  US$4.4025    318,035   $3,037,087    474,332   $2,198,121 
         318,035   $3,037,087    474,332   $2,198,121 

 

1)The warrants expire February 26, 2029.

 

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   September 30, 2025   December 31, 2024 
Risk free interest rate   3.76%   4.38%
Expected volatility   128.72%   124.06%
Expected life   3.41 years    4.16 years 
Expected dividend yield   0%   0%

 

As at September 30, 2025, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of warrants outstanding September 30, 2025   

Number of warrants outstanding December

31, 2024

 
October 30, 2023  October 30, 2026  CAD$23.20    12,800      12,800  
October 30, 2023  October 30, 2028  CAD$3.3086    256,000      256,000  
February 26, 2024  February 26, 2027  US$8.44    26,800      26,800  
February 26, 2024  February 26, 2029  US$4.4025    318,035     

474,332

 
April 29, 2024  April 29, 2029  CAD$3.3086    540,541      540,541  
April 29, 2024  April 29, 2027  CAD$11.06    27,028      27,028  
August 21, 2024  August 21, 2029  CAD$

3.3086

    -      666,667  
August 21, 2024  August 21, 2027  CAD$5.12    -      33,334  
November 19, 2024  November 19, 2029  CAD$3.3086    266,667      -  
May 5, 2025  May 5, 2030  CAD$3.9779    485,000      -  
May 5, 2025  May 5, 2028  CAD$3.632    90,750      -  
June 12, 2025  June 12, 2030  CAD$5.0768    3,763,500      -  
July 21, 2025  July 21, 2030  CAD$7.3579    4,572,895      -  
July 21, 2025  July 21, 2028  CAD$9.1973    233,644      -  
            10,593,660      2,037,502  

 

The weighted average remaining contractual life of warrants outstanding as of September 30, 2025, was 4.59 years (December 31, 2024 – 4.6 years).

 

15

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.SHARE CAPITAL (CONT’D)
   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2023   342,992   $15.75 
Issued   5,376,370    3.35 
Exercised   (1,991,668)   0.96 
Expired   (10,192)   125.00 
Outstanding, December 31, 2024   3,717,502   $5.16 
Issued   12,587,289    5.81 
Exercised   (5,711,131)   (4.24)
Outstanding September 30, 2025   10,593,660   $6.01 

 

13. SEGMENTED INFORMATION

 

The Company operates in 2 reportable segments. The Company organizes its two segments based on its product line as well as a corporate segment. The two segments are Drones and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV) while the Corporate segment includes all costs not directly associated with the Drone segment. The Company aggregates the information for the segments by analyzing the revenue stream and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

16

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SEGMENTED INFORMATION (CONT’D)

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, chief operating officer and chief financial officer.

 

 

September 30, 2025  Drones   Corporate   Total 
Sales of goods  $5,065,682   $-   $5,065,682 
Provision of services   753,281    -    753,281 
Total revenue   5,818,963    -    5,818,963 
Segment loss (income)   4,873,571    9,606,914    14,480,485 
Finance and other costs   403,392    7,102    410,494 
Depreciation   226,771    7,632    234,403 
Amortization   6,771    -    6,771 
Change in fair value of derivative liability   -    (1,860,107)   (1,860,107)
Loss on write-off of notes receivable   -    69,646    69,646 
Loss on write down of inventory   15,091    -    15,091 
Net loss for the period  $5,525,596   $7,831,187   $13,356,783 

 

September 30, 2024  Drones   Corporate   Total 
Sales of goods  $3,953,974   $-   $3,953,974 
Provision of services   993,920    -    993,920 
Total revenue   4,947,894    -    4,947,894 
Segment loss (income)   4,488,920   $1,165,111    5,654,031 
Finance and other costs   85,436    -    85,436 
Depreciation   412,544    11,495    424,039 
Amortization   8,464    -    8,464 
Change in fair value of derivative liability   -    2,788,734    2,788,734 
Loss on write-off of notes receivable   -    18,425    18,425 
Loss on write down of inventory   176,422    -    176,422 
Net loss for the period  $5,171,786   $3,983,765   $9,155,551 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

   September 30, 2025   December 31, 2024 
Non-current assets          
Canada  $904,828   $1,117,513 
United States  $201,104    - 
   $1,105,932   $1,117,513 

 

   2025   2024   2025   2024 
   For the three months ended September 30,   For the nine months ended September 30, 
   2025   2024   2025   2024 
Revenue                
Canada  $2,149,141   $1,860,227   $5,804,975   $4,913,720 
United States   6,852    25,095    13,988    34,174 
Revenue  $2,155,993   $1,885,322   $5,818,963   $4,947,894 

 

17

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

14. OFFICE AND MISCELLANEOUS

 

   2025   2024   2025   2024 
   For the three months ended September 30,   For the nine months ended September 30, 
   2025   2024   2025   2024 
Advertising, Marketing, and Investor Relations  $550,263   $240,942   $1,096,629   $649,700 
Compliance fees   137,649    63,988    436,602    205,753 
Business development   163,230    61,249    508,255    193,842 
General freight   77,446    39,316    276,308    84,908 
General office   402,208    215,201    892,162    565,352 
Office and Miscellaneous Expenses  $1,330,796   $620,696   $3,209,956   $1,699,555 

 

15. OTHER EXPENSE

 

   2025   2024   2025   2024 
   For the three months ended September 30,   For the nine months ended September 30, 
   2025   2024   2025   2024 
Share issue costs  $-   $60,179   $-   $1,254,629 
Write off of accounts (payable) receivable   (48,128)   40,409    (23,486)   (8,424)
Other   164    (3,307)   3,655    (9,036)
Total other expenses  $(47,964)  $97,281   $(19,831)  $1,237,169 

 

16. RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $124,208 (2024 - $64,463) and $302,886 (2024 - $190,164) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $1,874).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $109,438 (2024 - $109,438) and $520,089 (2024 - $325,125) respectively. As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $nil).

 

On May 2, 2022, the Company and entered into an agreement with Scott Larson, a director, to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the three and nine months ended September 30, 2025, the Company incurred fees of $30,744 (2024 - $41,911) and $70,203 (2024 - $119,335). As at September 30, 2025, the Company was indebted to this company in the amount of $nil (2024 - $9,000).

 

18

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

16.RELATED PARTY TRANSACTIONS (CONT’D)

 

Trade receivables/payables and accrued receivables/payables:

 

As at September 30, 2025, the Company had $122,965 (2024 - $10,874) payable to other related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three and nine months ended September 30, 2025 and 2024 included:

 

   2025   2024   2025   2024 
   For the three months ended September 30,   For the nine months ended September 30, 
   2025   2024   2025   2024 
Director fees  $122,965   $131,469   $394,803   $375,368 
Salaries   632,338    127,329    1,087,594    396,916 
Share-based payments   297,738    223,364    697,301    527,224 
Total  $1,053,041   $482,162   $2,179,698   $1,299,508 

 

Other related party transactions

 

   2025   2024   2025   2024 
   For the three months ended September 30,   For the nine months ended September 30, 
   2025   2024   2025   2024 
Management fees paid to a company controlled by CEO and director  $109,438   $109,437   $520,089   $325,125 
Management fees paid to a company that the CEO holds an economic interest in   124,208    64,463    302,886    190,164 
Management fees paid to a company controlled by a director   30,744    41,910    70,203    119,335 
Management fees paid to a company, total   $264,390   $215,810   $893,178   $634,624 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The majority of cash is deposited in bank accounts held with a major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies.

 

19

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

17.FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Receivables

 

Receivables primarily consist of trade receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial assets are measured at fair value through profit and loss.

 

September 30, 2025  Level 1   Level 3   Total 
Equity securities in investee companies  $21,428   $-   $21,428 
Derivative liability   -    (3,037,087)   (3,037,087)
Total  $21,428   $(3,037,087)  $(3,015,659)

 

December 31, 2024  Level 1   Level 3   Total 
Equity securities in investee companies  $14,286   $-   $14,286 
Derivative liability   -    (2,198,121)   (2,198,121)
Total  $14,286   $(2,198,121)  $(2,183,835)

 

20

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2025

Expressed in Canadian Dollars (unaudited)

 

 

17.FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

Type   Valuation technique   Key inputs   Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

● Share price

● Risk free interest rate

● Dividend yield

Key unobservable inputs

● Expected volatility

 

The estimated fair value would increase (decrease) if:

● The price was higher (lower)

● The risk-free rate was higher (lower)

● The dividend yield was lower (higher)

● The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

       Impact on comprehensive loss 
Unobservable Inputs  Change   Nine months ended
September 30, 2025
   Year ended
December 31, 2024
 
Volatility   20%  $154,683   $201,109 

 

18. SUBSEQUENT EVENTS

 

Subsequent to September 30, 2025, there have been a total of 5,622,994 warrants exercised for total proceeds of CAD$ 28,949,428 and a total of 378,222 broker warrants exercised for total proceeds of $3,128,947. Warrant and broker warrants exercises were from the following issuances:

 

Warrants        
Issuance  Number exercised   Proceeds 
October 30,2023   

256,000

   $

847,429

 
February 26, 2024   256,124   1,580,782 
April 29, 2024   

540,540

    

1,789,333

 
November 19, 2024   266,667    882,204 
May 5, 2025   464,000    1,845,752 
June 12, 2025   2,762,500    14,050,264 
July 21, 2025   1,077,163    7,953,664 
    5,622,994   $28,949,428 

 

Broker Warrants        
Issuance  Number exercised   Proceeds 
February 26, 2024   26,800   $315,267 
April 29, 2024   27,028    304,854 
May 5, 2025   90,750    333,812 
July 21, 2025   233,644    2,175,014 
    378,222   $3,128,947 
Total exercises   6,001,216   $32,078,375 

 

21